Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Novartis AG ADS (NY: NVS)
74.62 USD  UNCHANGED
Official Closing Price  /  Updated: 6:40 PM EDT, May 22, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Novartis AG ADS
 
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
INTERPHEX 2013: It's a Wrap on Pharma's Biggest Conference of the Year, an Industrial Info News Alert
April 30, 2013
from Marketwired News Releases
Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts
April 26, 2013
- Discounts and rebates by pharmaceutical companies are a customary, appropriate and legal practice as recognized by the Government Read More
from PR Newswire
Got BIO? Better Get It! BIO 2013 Report Credits Industry With 1.6 Million High-Income U.S. Jobs, an Industrial Info News Alert
April 26, 2013
from Marketwired News Releases
Malaria No More Announces Innovative Partners For Its 'Power Of One' Malaria Campaign
April 25, 2013
Novartis, Alere, Time Warner, Twitter, and more sign on to help close malaria testing and treatment gaps in Africa Read More
from PR Newswire
Free Research Reports on BA, BYD, NVS and SO Issued by the Paragon Report
April 25, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Malaria No More Announces Innovative Partners For Its 'Power Of One' Malaria Campaign
April 25, 2013
Novartis, Alere, Time Warner, Twitter, and more sign on to help close malaria testing and treatment gaps in Africa Read More
from PR Newswire
Free Research Reports on NAT, NVS, RBY and YGE Issued by the Paragon Report
April 03, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Morning Research on Teva Pharma, Orexigen Therapeutics, Zoetis, and Novartis
April 03, 2013
from PR Newswire
The Real Story Behind MYL, JCI, NVS and WMB
March 19, 2013
from Marketwired News Releases
The Real Story Behind ACE, AEM, DHI and NVS
March 13, 2013
from Marketwired News Releases
Aggressive R&D Initiatives and Innovative Pipelines - Research Report on J&J, Merck, AbbVie, Novartis, and GSK
March 07, 2013
from PR Newswire
Teva Pharma, Zoetis, Orexigen Therapeutics, Novartis, and Actavis Early Briefing and Review
March 05, 2013
from PR Newswire
Coming off a Healthy Pulse - Research Report on Pfizer Inc., Johnson & Johnson, Abbott Laboratories, AstraZeneca plc. and Novartis AG
February 19, 2013
from PR Newswire
Free Research Report on Novartis AG, Diamond Offshore Drilling, Inc., SLM Corp., Xilinx, Inc. and Cree, Inc.
February 15, 2013
from Marketwired News Releases
Perfect Trade Setups, How to Play CELG, NVS, GSK and BMY
January 14, 2013
from Marketwired News Releases
XL, KKR, NVS and CX Freshly Hit a New 52-Week High
January 11, 2013
from Marketwired News Releases
The Zacks Analyst Blog Highlights: AstraZeneca, Mylan Pharma, Novartis, Teva Pharmaceuticals and Merck
December 20, 2012
from PR Newswire
Pharma-Biotech Industry Invests More Than $12 Billion in 2012 North American Project Starts, an Industrial Info News Alert
December 18, 2012
from Marketwired News Releases
Recently Launched Products Support Novartis Sales in Third Quarter, Offsetting Patent Expiry; Pharmaceuticals Well-Positioned with Further Pipeline Progress
October 25, 2012
from Business Wire News Releases
Industry Without Borders: Pharmaceutical-Biotech Capital Investment Leaps Around the Globe, an Industrial Info News Alert
October 17, 2012
from Marketwired News Releases
Leeza Gibbons joins Novartis to improve caregiving experience for millions of Americans through real-world peer advice on AlzheimersDisease.com
October 16, 2012
- Leeza and family share highs, lows and insights about caring for her mother with Alzheimer's disease in new video series Read More
from PR Newswire
A Refreshing Outlook -- Consensus Reports on Cell Therapeutics, Inc. and Novartis AG
September 13, 2012
from Marketwired News Releases
Where We Are Headed -- New Outlook on Warner Chilcott plc and Novartis AG
September 07, 2012
from Marketwired News Releases
Higher dose of Novartis drug Exelon® Patch approved by FDA for patients with mild to moderate Alzheimer's disease
September 04, 2012
-- Approval based on efficacy and safety demonstrated in long-term study comparing 13.3 mg/24 h to 9.5 mg/24 h in declining mild to moderate Alzheimer's patients Read More
from PR Newswire
A Little Homework Goes a Long Way - Research & Analysis on Warner Chilcott plc and Novartis AG
August 29, 2012
from Marketwired News Releases
Immunovative, Inc. Given a "Buy" Rating and $1.70 Price Target
August 07, 2012
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS ALERT. Read More
from Marketwired News Releases
Today's Hot Stocks: Knight Capital Group, Genworth Financial, Best Buy, General Motors, Yamana Gold, and Novartis AG
August 02, 2012
from PR Newswire
Critical Diagnostics Adds Two More IVD Industry Veterans
August 01, 2012
from Business Wire News Releases
Equities Lead Investor Sentiment - Research Report on Novartis AG (ADR) and Bristol Myers Squibb Co.
June 14, 2012
from Marketwired News Releases
Upcoming Economic Outlook - Report Highlights Novartis AG (ADR) and Abbott Laboratories
June 01, 2012
from Marketwired News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here